Mirtazapine EP Impurity F is a structurally related degradation byproduct of the antidepressant mirtazapine, characterized by a substituted thiazole ring system with a piperazine side chain and a methoxyphenyl moiety. The compound features a secondary amine, an amide linkage, and aromatic heterocycles, differing from the parent drug by a methylene bridge oxidation to a hydroxyl group. This impurity arises via oxidative degradation under acidic conditions. It serves as an HPLC reference standard for quantifying process-related impurities in mirtazapine active pharmaceutical ingredients.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1444252 โ | 50 mg | USD 813.00 |
CN1CCN2C(C1)C3=CC=CC=C3C(=O)C4=C2N=CC=C4
InChI=1S/C17H17N3O/c1-19-9-10-20-15(11-19)12-5-2-3-6-13(12)16(21)14-7-4-8-18-17(14)20/h2-8,15H,9-11H2,1H3
RZDFSDWHGNDESU-UHFFFAOYSA-N